Rananna, Israel

Adrian Gilbert

USPTO Granted Patents = 6 



Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 122(Granted Patents)


Location History:

  • Kfar-Saba, IL (2001)
  • Kfar Sava, IL (2006)
  • Ra'anana, IL (2007)
  • Ra'nanna, IL (2011 - 2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian Gilbert

Introduction

Adrian Gilbert is a notable inventor based in Rananna, IL, recognized for his significant contributions to the pharmaceutical industry. With a total of 6 patents, he has made strides in developing innovative drug formulations that address various medical needs.

Latest Patents

Among his latest patents, Gilbert has developed stable laquinimod preparations. This invention relates to a pharmaceutical composition that includes a pharmaceutically acceptable salt of N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, N-methylglucamine, and a pharmaceutically acceptable carrier. Additionally, he has disclosed formulations of ladostigil tartrate, which encompass pharmaceutical compositions, processes for manufacture, and their uses.

Career Highlights

Throughout his career, Adrian Gilbert has worked with prominent companies such as Teva Pharmaceutical Industries Limited and Yeda Research and Development & Co. Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Gilbert has collaborated with several professionals in the field, including Daniella Licht and Milka Linenberg. These partnerships have fostered innovation and enhanced the quality of his research.

Conclusion

Adrian Gilbert's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…